The stages of type 1 diabetes
Last reviewed November 17, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.
Type 1 diabetes used to be defined by the day someone became unwell. It is now defined by the immune process, which starts years earlier and can be detected.
That reframing is recent, and it is what makes delay therapy and planned diagnosis possible instead of an emergency admission.
Related pages: Type 1 diabetes
The bottom line
- Stage 1 is two or more autoantibodies with normal blood sugar.
- Stage 2 is two or more autoantibodies with abnormal blood sugar but no symptoms.
- Stage 3 is clinical onset with symptoms.
- Nearly everyone at stage 1 eventually progresses, though the timing varies widely.
- The honeymoon phase after diagnosis reflects surviving beta cells and is temporary.
- How to predict the speed of progression for an individual.
- Whether stage 1 and 2 should be called diabetes at all.
- How much residual function can be preserved long term.
The story, step by step
- 1. Stage 1 ()
- 2. Stage 2 ()
- 3. Stage 3 ()
- 4. The honeymoon ()
What the evidence labels mean
Antibodies, normal glucose
What happens
The disease has begun; nothing is wrong yet.
What the research shows
- Stage 1 means two or more islet autoantibodies are present and blood glucose is still entirely normal.
- There are no symptoms. The person feels completely well and would pass any standard diabetes test.
- Nearly everyone at this stage eventually progresses to clinical disease, though it may take years or decades.
- In children, progression tends to be faster than in adults.
- This is now formally classified as early-stage type 1 diabetes, which is a significant change: the diagnosis no longer requires high blood sugar.
- Identifying people here allows monitoring, education about symptoms, and consideration of therapy to delay the next stage.
Why it matters
Being told you have a disease while feeling entirely well is a difficult thing to be given, and it is also the point at which the most can be done.
What's still uncertain
- How to communicate a stage 1 diagnosis well.
- Whether all stage 1 inevitably progresses given enough time.
Read more
- NIH: TrialNet and type 1 diabetes prevention researchGovernment
- American Diabetes Association: standards of care resourcesNonprofit
- NIDDK: Type 1 diabetesGovernment
Next: Stage 2
Glucose starting to drift
What happens
Still no symptoms.
What the research shows
- Stage 2 means two or more autoantibodies plus abnormal glucose: impaired fasting glucose, impaired glucose tolerance, or a rising A1C, without symptoms.
- Beta-cell function has declined enough to be measurable but the person still feels well.
- Progression to stage 3 from here is typically within a few years, and faster in children.
- This is the stage at which teplizumab, an immune-modulating antibody treatment, is licensed in the United States to delay clinical onset.
- Monitoring at this stage is usually with periodic glucose tolerance testing, A1C and sometimes continuous glucose monitoring.
- Knowing someone is at stage 2 means the eventual diagnosis is planned rather than an emergency.
Why it matters
Diagnosing at stage 2 removes much of the danger of the transition: ketoacidosis at first presentation becomes far less likely.
What's still uncertain
- How long delay therapy postpones onset in practice.
- The optimal monitoring schedule at this stage.
Read more
- NIH: TrialNet and type 1 diabetes prevention researchGovernment
- American Diabetes Association: standards of care resourcesNonprofit
- FDA: drug and device informationGovernment
Next: Stage 3
Clinical diagnosis
What happens
Symptoms, and the day everyone remembers.
What the research shows
- Stage 3 is clinical type 1 diabetes: high blood glucose with symptoms, usually thirst, frequent urination, weight loss and fatigue.
- This is the point at which most people are diagnosed, often without any knowledge of the previous stages.
- A substantial proportion of children, and a meaningful share of adults, present in diabetic ketoacidosis, which is both dangerous and avoidable with earlier recognition.
- Insulin treatment begins immediately and continues for life.
- Stage 3 does not mean all beta cells are gone. Many people retain some function for months or years.
- Some classifications add a stage 4, long-standing established disease.
Why it matters
The high rate of ketoacidosis at first diagnosis is the strongest practical argument for screening, because it is entirely a consequence of finding the disease late.
What's still uncertain
- How to reduce ketoacidosis at presentation.
- Whether earlier diagnosis improves long-term control.
Read more
- CDC: Type 1 diabetesGovernment
- NIDDK: Type 1 diabetesGovernment
- American Diabetes Association: standards of care resourcesNonprofit
Next: The honeymoon
A temporary reprieve
What happens
Real, and widely misread.
What the research shows
- After starting insulin, surviving beta cells often recover some function, because relieving the strain of very high glucose allows them to work again.
- Insulin requirements drop, sometimes dramatically, and blood sugars become unusually easy to control. This is the honeymoon phase.
- It typically begins within weeks of diagnosis and lasts months, occasionally a year or more.
- It does not mean the diabetes has gone away or was misdiagnosed. The autoimmune process continues.
- Insulin is reduced rather than stopped during it, because continuing some insulin appears to help preserve remaining function.
- When it ends, doses rise again, which can feel like a second diagnosis and is worth warning people about in advance.
Why it matters
Families frequently interpret the honeymoon as recovery, and the end of it as something having gone wrong. Explaining it beforehand prevents both.
What's still uncertain
- Whether any treatment extends the honeymoon meaningfully.
- Whether preserving residual function changes long-term outcomes.
Read more
- NIDDK: Type 1 diabetesGovernment
- American Diabetes Association: standards of care resourcesNonprofit
- MedlinePlus: Type 1 diabetesGovernment